J. K. Smith
University of Nottingham
12 Papers
71 Citations
J. K. Smith is an academic researcher from University of Nottingham. The author has contributed to research in topics: Diverticular disease & Abdominal pain. The author has an hindex of 7, co-authored 12 publications. Previous affiliations of J. K. Smith include Nottingham University Hospitals NHS Trust.
Chat about Author
Papers
Visceral hypersensitivity in symptomatic diverticular disease and the role of neuropeptides and low grade inflammation
David J. Humes,J Simpson,J. K. Smith,Paul Sutton,Abed M. Zaitoun,D. Bush,Andrew J. Bennett,John H. Scholefield,Robin C. Spiller +8 more
TL;DR: The aim was to assess visceral sensitivity in patients with diverticular disease and its association with markers of previous inflammation and neuropeptides.
128
The role of routine assays of serum amylase and lipase for the diagnosis of acute abdominal pain.
Paul Sutton,David J. Humes,Gemma Purcell,J. K. Smith,Frances Whiting,Thomas M. Wright,Linda Morgan,Dileep N. Lobo +7 more
TL;DR: Routine measurements of serum amylase and lipase are unhelpful in the diagnosis of acute abdominal pain unless there is clinical suspicion of acute pancreatitis, in which case assay of lipase alone is preferable to assay of amyl enzyme alone or both enzymes.
Temporal assessment of pancreatic blood flow and perfusion following secretin stimulation using noninvasive MRI.
TL;DR: To dynamically quantify pancreatic perfusion and flow within the arteries supplying the pancreas in response to secretin stimulation.
19
OC-119 Mechanistic randomised control trial of mesalazine in symptomatic diverticular disease
J. K. Smith,David J. Humes,Klara Garsed,Ching Lam,Abed M. Zaitoun,Andrew J. Bennett,John H. Scholefield,Robin C. Spiller +7 more
TL;DR: A first parallel design, double blind, randomised placebo controlled trial of an anti-inflammatory drug, mesalazine in SDD significantly reduced important inflammatory and pain genes including those involved in response to bacterial ligands.
18
•Journal Article
Colonic diverticular disease.
TL;DR: A systematic review of the evidence relating to the effectiveness and safety of the following interventions: antispasmodics, elective surgery, increasing fibre intake with bran or ispaghula husk, lactulose, medical treatment, mesalazine, methylcellulOSE, rifaximin, and surgery.
17